GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actinogen Medical Ltd (ASX:ACW) » Definitions » Scaled Net Operating Assets

Actinogen Medical (ASX:ACW) Scaled Net Operating Assets : 0.04 (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Actinogen Medical Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Actinogen Medical's operating assets for the quarter that ended in Dec. 2023 was A$2.69 Mil. Actinogen Medical's operating liabilities for the quarter that ended in Dec. 2023 was A$2.14 Mil. Actinogen Medical's Total Assets for the quarter that ended in Jun. 2023 was A$15.21 Mil. Therefore, Actinogen Medical's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2023 was 0.04.


Actinogen Medical Scaled Net Operating Assets Historical Data

The historical data trend for Actinogen Medical's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Actinogen Medical Scaled Net Operating Assets Chart

Actinogen Medical Annual Data
Trend Jun14 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.39 0.36 0.30 0.22 0.70

Actinogen Medical Semi-Annual Data
Jun14 Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.22 0.07 0.28 0.04 0.75

Competitive Comparison of Actinogen Medical's Scaled Net Operating Assets

For the Biotechnology subindustry, Actinogen Medical's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Actinogen Medical's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Actinogen Medical's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Actinogen Medical's Scaled Net Operating Assets falls into.



Actinogen Medical Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Actinogen Medical's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Jun. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(A: Jun. 2024 )
=(Operating Assets (A: Jun. 2024 )-Operating Liabilities (A: Jun. 2024 ))/Total Assets (A: Jun. 2023 )
=(11.861-1.296)/15.209
=0.69

where

Operating Assets(A: Jun. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=21.312 - 9.451
=11.861

Operating Liabilities(A: Jun. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=1.615 - 0.258 - 0.061
=1.296

Actinogen Medical's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Dec. 2023 )
=(Operating Assets (Q: Dec. 2023 )-Operating Liabilities (Q: Dec. 2023 ))/Total Assets (Q: Jun. 2023 )
=(2.692-2.141)/15.209
=0.04

where

Operating Assets(Q: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=14.164 - 11.472
=2.692

Operating Liabilities(Q: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=2.186 - 0 - 0.045
=2.141

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Actinogen Medical Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Actinogen Medical's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Actinogen Medical Business Description

Traded in Other Exchanges
Address
109 Pitt Street, Level 9, Suite 901, Sydney, NSW, AUS, 2000
Actinogen Medical Ltd is a biotechnology company. The company develops drugs for Alzheimer's disease and the cognitive decline associated with other neurological diseases. It is focused on the clinical development of Xanamem, an oral medication for neurological diseases amenable to its mechanism of lowering cortisol in brain cells. Geographically, the company's income is derived in Australia.

Actinogen Medical Headlines

From GuruFocus

Stocks That Are Making A Good Come Back

By reports.droy reports.droy 03-10-2015

Accuride Corporation: Earnings Report For Q2 2014

By Black Iguana Nitish 10-13-2014